ProA Capital has launched its third buyout fund, ProA Capital Iberian Buyout Fund III, according to public documents filed by the company with the Spanish regulator, Comisión Nacional del Mercado de Valores (CNMV).
New and historical backers invest in Belgium-based Imcyse, a developer of immunotherapies
Buyout of the baking product company is the GP's fifth UK deal since opening a Manchester office
Sale ends an eight-year holding period for the GP, which owned an 83.4% stake in the company
Fresh capital will be used to develop BioSerenity's products beyond their initial focus